In this manuscript we report findings that provide further insight into the mechanism of HGF-mediated rescue of BRAF or MEK inhibition in BRAFV600E mutant melanoma and demonstrate that MET and GAB1 (a key adaptor protein in HGF/MET signaling) are uniquely upregulated following MAPK pathway inhibition. The gene discussed is MET; the disease is melanoma.